Qelbree ER 100 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB26FAUAD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,701
Award facts
- Contract value 100% obligated
- $2,701.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,701.18 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of QELBREE ER 100 mg capsules (30-count). This firm fixed-price delivery order, issued without set-aside designation on October 29, 2025, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with completion targeted for October 30, 2025. DMS Pharmaceutical Group represents a critical supplier within the federal pharmaceutical supply chain and has demonstrated substantial contracting activity with the Defense Logistics Agency's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes the company to supply a comprehensive range of pharmaceuticals and medical consumables to support Department of Defense healthcare operations globally. The company's established performance on numerous prior delivery orders and its extensive product portfolio—spanning branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals—position it as a key pharmaceutical supplier for military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DB26FAUAD?
SPE2DB26FAUAD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FAUAD worth?
The government has obligated $2,701 on SPE2DB26FAUAD.
Is contract SPE2DB26FAUAD an order under another contract?
Yes. SPE2DB26FAUAD is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FAUAD competed?
The extent of competition for SPE2DB26FAUAD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award